Ledger.Open graph →
SEC Form D · filed April 27, 2011

EIGER BIOPHARMACEUTICALS INC

Offering
$5.0M
Sold
$3.5M
Exemption
—
Industry
Biotechnology
Location
PALO ALTO, CA
Type
—

People & firms on this filing (12)

Nina Kjellson · Palo Alto, CADirectorDavid Cory · Palo Alto, CAExec · DirectorJeffrey Glenn · Palo Alto, CADirectorGlen Sato · Palo Alto, CAExecEd Engleman · Palo Alto, CADirectorPaul Truex · Palo Alto, CADirectorWilliam F. Ball Iii · Warrenton, VAExec · DirectorBrian Beverly · Des Moines, IADirectorRobert D. Grote · Des Moines, IADirectorJeanne K. Johnson · Des Moines, IADirectorEsplin Keith · Rexburg, IDDirectorLaura G. King · Madison, WIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗